Growth Metrics

Veracyte (VCYT) Non-Current Deffered Revenue: 2012-2021

Historic Non-Current Deffered Revenue for Veracyte (VCYT) over the last 9 years, with Dec 2021 value amounting to $343,000.

  • Veracyte's Non-Current Deffered Revenue fell 62.78% to $278,000 in Q1 2022 from the same period last year, while for Mar 2022 it was $278,000, marking a year-over-year decrease of 62.78%. This contributed to the annual value of $343,000 for FY2021, which is 58.62% down from last year.
  • Veracyte's Non-Current Deffered Revenue amounted to $343,000 in FY2021, which was down 58.62% from $829,000 recorded in FY2020.
  • In the past 5 years, Veracyte's Non-Current Deffered Revenue ranged from a high of $4.2 million in FY2017 and a low of $343,000 during FY2021.
  • Over the past 2 years, Veracyte's median Non-Current Deffered Revenue value was $586,000 (recorded in 2020), while the average stood at $586,000.
  • Data for Veracyte's Non-Current Deffered Revenue shows a maximum YoY crashed of 58.62% (in 2021) over the last 5 years.
  • Yearly analysis of 4 years shows Veracyte's Non-Current Deffered Revenue stood at $4.2 million in 2017, then decreased by 6.50% to $3.9 million in 2018, then reached $829,000 in 2020, then plummeted by 58.62% to $343,000 in 2021.